PFIZER INC. - Daily - Technical analysis published on 10/16/2019 (GMT)
- 327
- 0
- Who voted?
Oops, I was wrong about that analysis. My threshold for invalidation has been broken.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : INVALID
A split or consolidation has occurred on this instrument. There is no more graph available on this analysis.
Summary of the analysis
Trends
Court terme:
Bullish
De fond:
Bearish
Technical indicators
61%
0%
39%
My opinion
Bearish under 37.41 USD
My targets
35.43 USD (-2.93%)
33.64 USD (-7.84%)
My analysis
In a bearish trend, the price of PFIZER INC. tries to inflate a little with a slight short-term rebound. At this stage, no trend reversal is in sight. Globally, sellers have the upper hand. Traders may allow themselves to trade short positions (for sale) as long as the price remains below the resistance located at 37.41 USD. A bearish break in the support located at 35.43 USD would revive the bearish momentum and fuel the basic trend. Then the price could move towards 33.64 USD. Then 31.75 USD by extension. It would be safer to wait for a bearish break in the support located at 35.43 USD before allowing yourself to re trade short positions (for sale) on PFIZER INC.. PS: if there is a bullish break in the resistance located at 37.41 USD we suggest that you produce a new automated technical analysis. In fact, conditions should have changed. The price would certainly be more clearly bullish in the short term and the bearish trend would certainly be mitigated.
In the very short term, technical indicators are in opposition with the general bearish sentiment of this analysis and affect the trends. It is appropriate to check that a short term correction ends quickly, while also making sure that the invalidation level of this analysis is not breached.
FORCE
0
10
0
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by Vincent Launay. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
PFIZER INC. rating 36.50 USD. On the day, this instrument gained +0.55% and was between 36.41 USD and 36.74 USD. This implies that the price is at +0.25% from its lowest and at -0.65% from its highest.36.41
36.74
36.50
The Central Gaps scanner detects the formation of a bullish gap marking the strong presence of buyers against sellers at the opening. This formed a quotation gap.
Opening Gap UP
Type : Bullish
Timeframe : Openning
So that you have an overall view of the price change, here is a table showing the variations over several periods:
Technical
Technical analysis of this Daily chart of PFIZER INC. indicates that the overall trend is bearish. 64.29% of the signals given by moving averages are bearish. Caution: the slightly bullish signals currently being given by short-term moving averages indicate that this bearish trend may be slowing down. There is no crossing of moving average by the price or crossing of moving averages between themselves.
The technical indicators are bullish. There is still some doubt about the price increase.
Caution: the Central Indicators scanner currently detects an excess:
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : Daily
Pivot points : price is over resistance 1
Type : Neutral
Timeframe : Daily
Aroon indicator bullish trend
Type : Bullish
Timeframe : Daily
Price is back over the pivot point
Type : Bullish
Timeframe : Weekly
Central Patterns, the market scanner focusing on chart patterns, resistances and supports found these results:
Resistance of channel is broken
Type : Bullish
Timeframe : Daily
Resistance of triangle is broken
Type : Bullish
Timeframe : Daily
No result was found by the Central Candlesticks scanner on Japanese candlesticks.
ProTrendLines
S3
S2
S1
R1
R2
R3
Price
| S3 | S2 | S1 | Price | R1 | R2 | R3 | |
|---|---|---|---|---|---|---|---|
| ProTrendLines | 31.75 | 33.64 | 35.43 | 36.50 | 37.41 | 38.91 | 40.89 |
| Change (%) | -13.01% | -7.84% | -2.93% | - | +2.49% | +6.60% | +12.03% |
| Change | -4.75 | -2.86 | -1.07 | - | +0.91 | +2.41 | +4.39 |
| Level | Minor | Major | Intermediate | - | Intermediate | Major | Intermediate |
To determine price objectives, it is also possible to use the pivot points. Here is the price position in relation to pivot points:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 35.70 | 35.84 | 36.07 | 36.21 | 36.44 | 36.58 | 36.81 |
| Camarilla | 36.20 | 36.23 | 36.27 | 36.30 | 36.33 | 36.37 | 36.40 |
| Woodie | 35.75 | 35.86 | 36.12 | 36.23 | 36.49 | 36.60 | 36.86 |
| Fibonacci | 35.84 | 35.98 | 36.07 | 36.21 | 36.35 | 36.44 | 36.58 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 34.33 | 34.88 | 35.49 | 36.04 | 36.65 | 37.20 | 37.81 |
| Camarilla | 35.79 | 35.90 | 36.00 | 36.11 | 36.22 | 36.32 | 36.43 |
| Woodie | 34.37 | 34.90 | 35.53 | 36.06 | 36.69 | 37.22 | 37.85 |
| Fibonacci | 34.88 | 35.32 | 35.59 | 36.04 | 36.48 | 36.75 | 37.20 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 32.79 | 34.15 | 35.04 | 36.40 | 37.29 | 38.65 | 39.54 |
| Camarilla | 35.31 | 35.52 | 35.72 | 35.93 | 36.14 | 36.34 | 36.55 |
| Woodie | 32.56 | 34.03 | 34.81 | 36.28 | 37.06 | 38.53 | 39.31 |
| Fibonacci | 34.15 | 35.01 | 35.54 | 36.40 | 37.26 | 37.79 | 38.65 |
Numerical data
The following are the details of the technical indicators and moving averages that were collected to generate this technical analysis:
Technical indicators
Moving averages
| RSI (14): | 54.91 | |
| MACD (12,26,9): | -0.0900 | |
| Directional Movement: | 5.18 | |
| AROON (14): | 57.14 | |
| DEMA (21): | 35.82 | |
| Parabolic SAR (0,02-0,02-0,2): | 35.05 | |
| Elder Ray (13): | 0.60 | |
| Super Trend (3,10): | 36.89 | |
| Zig ZAG (10): | 36.50 | |
| VORTEX (21): | 0.9700 | |
| Stochastique (14,3,5): | 83.62 | |
| TEMA (21): | 36.09 | |
| Williams %R (14): | -11.26 | |
| Chande Momentum Oscillator (20): | 0.28 | |
| Repulse (5,40,3): | -0.1400 | |
| ROCnROLL: | -1 | |
| TRIX (15,9): | -0.0700 | |
| Courbe Coppock: | 1.27 |
| MA7: | 35.95 | |
| MA20: | 35.94 | |
| MA50: | 35.85 | |
| MA100: | 38.97 | |
| MAexp7: | 36.06 | |
| MAexp20: | 36.00 | |
| MAexp50: | 36.70 | |
| MAexp100: | 38.00 | |
| Price / MA7: | +1.53% | |
| Price / MA20: | +1.56% | |
| Price / MA50: | +1.81% | |
| Price / MA100: | -6.34% | |
| Price / MAexp7: | +1.22% | |
| Price / MAexp20: | +1.39% | |
| Price / MAexp50: | -0.54% | |
| Price / MAexp100: | -3.95% |
News
The last news published on PFIZER INC. at the time of the generation of this analysis was as follows:
- Pfizer Presents Positive Phase 3 Data at the 28th Congress of the European Academy of Dermatology and Venereology for Abrocitinib in Moderate to Severe Atopic Dermatitis
- Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer
- Pfizer Inc. Awards “Golden Tickets” to Neutrolis and Mediar Therapeutics
- Ian Read to Retire as Executive Chairman of Pfizer’s Board of Directors; Chief Executive Officer Dr. Albert Bourla Named Chairman
- Pfizer Announces Positive Top-Line Results from Second Pivotal Phase 3 Study of Investigational Oral JAK1 Candidate, Abrocitinib, in Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis
This member declared not having a position on this financial instrument or a related financial instrument.
About author
Online
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis PFIZER INC. - Daily